| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-07 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |